Hospira propofol recall expanded; Portable high-tech unit IDs drug fakes;

> Hospira is expanding a recall that began in March of propofol; some containers may be contaminated with sub-visible inert stainless steel particles. Release

> A portable device from Gilden Photonics uses a light to compare spectral signatures, separating counterfeits from real drugs. Article

> SOHM, in Ahmadabad, India, has added 410 square meters of operations space and is separating drug and nutritional product manufacturing. Article

> The FDA has received reports of floating matter in IV bags manufactured by Claris; potentially affected products carry Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Alert

> Siegfried will supply the majority of sodium oxybate, the active pharmaceutical ingredient in Xyrem, to Jazz Pharmaceutical. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.